FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022606182> ?p ?o ?g. }

• W2022606182 endingPage "2344" @default.
• W2022606182 startingPage "2337" @default.
• W2022606182 abstract "Abstract Purpose: This study investigates the antiangiogenesis and antitumor efficacy of a recombinant protein composed of the three type 1 repeats (3TSR) of thrombospondin-1 in an orthotopic human pancreatic cancer model and provides useful preclinical data for pancreatic cancer treatment. Experimental Design: Human pancreatic cancer cells (AsPC-1) were injected into the pancreas of severe combined immunodeficient mice. The animals were treated with 3TSR (3 mg per kg per day) or PBS for 3 weeks. Subsequently, the effects of 3TSR on tumor growth, microvessel density, cancer cell proliferation, apoptosis, and endothelial cell apoptosis were analyzed. The in vitro effects of 3TSR on human pancreatic cancer cells were also studied. Results: 3TSR treatment significantly reduced angiogenesis and tumor growth of orthotopic pancreatic cancer. 3TSR-treated mice had a 69% reduction in tumor volume (316.6 ± 79.3 versus 1,012.2 ± 364.5 mm3; P = 0.0001), and a significant increase in tumor necrotic area. After 3TSR treatment, both the vessel number and average microvessel size were significantly decreased, and microvessel density was decreased from 8.0% to 3.7% (P &lt; 0.0001). The apoptotic rate of tumoral endothelial cells in 3TSR-treated tumors increased to 14.7% comparing to 4.2% in control tumors (P &lt; 0.0001). 3TSR showed no direct effects on pancreatic cancer cell proliferation or apoptosis either in vivo or in vitro. Conclusion: 3TSR, a domain of a natural occurring angiogenesis inhibitor, showed potent therapeutic effect in pancreatic cancer by inhibiting tumor angiogenesis and may prove to be a promising agent for clinical pancreatic cancer treatment." @default.
• W2022606182 created "2016-06-24" @default.
• W2022606182 creator A5008350987 @default.
• W2022606182 creator A5009798637 @default.
• W2022606182 creator A5053105738 @default.
• W2022606182 creator A5053619846 @default.
• W2022606182 creator A5065439532 @default.
• W2022606182 creator A5083192393 @default.
• W2022606182 date "2005-03-15" @default.
• W2022606182 modified "2023-09-27" @default.
• W2022606182 title "Antiangiogenic Treatment with the Three Thrombospondin-1 Type 1 Repeats Recombinant Protein in an Orthotopic Human Pancreatic Cancer Model" @default.
• W2022606182 cites W1549631663 @default.
• W2022606182 cites W1941829554 @default.
• W2022606182 cites W1974188350 @default.
• W2022606182 cites W1976757175 @default.
• W2022606182 cites W1978139448 @default.
• W2022606182 cites W1985804036 @default.
• W2022606182 cites W2003103533 @default.
• W2022606182 cites W2003851186 @default.
• W2022606182 cites W2007501886 @default.
• W2022606182 cites W2007799501 @default.
• W2022606182 cites W2012852444 @default.
• W2022606182 cites W2013192123 @default.
• W2022606182 cites W2015921272 @default.
• W2022606182 cites W2024626734 @default.
• W2022606182 cites W2034269086 @default.
• W2022606182 cites W2046507292 @default.
• W2022606182 cites W2048967458 @default.
• W2022606182 cites W2051563676 @default.
• W2022606182 cites W2054793295 @default.
• W2022606182 cites W2055515174 @default.
• W2022606182 cites W2059322719 @default.
• W2022606182 cites W2061270766 @default.
• W2022606182 cites W2062065058 @default.
• W2022606182 cites W2074857354 @default.
• W2022606182 cites W2075756262 @default.
• W2022606182 cites W2078446310 @default.
• W2022606182 cites W2078605907 @default.
• W2022606182 cites W2081143051 @default.
• W2022606182 cites W2081471836 @default.
• W2022606182 cites W2084089748 @default.
• W2022606182 cites W2094735302 @default.
• W2022606182 cites W2130987460 @default.
• W2022606182 cites W2131762447 @default.
• W2022606182 cites W2134674686 @default.
• W2022606182 cites W2171478975 @default.
• W2022606182 cites W4247785462 @default.
• W2022606182 cites W4252610833 @default.
• W2022606182 doi "https://doi.org/10.1158/1078-0432.ccr-04-1900" @default.
• W2022606182 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15788685" @default.
• W2022606182 hasPublicationYear "2005" @default.
• W2022606182 type Work @default.
• W2022606182 sameAs 2022606182 @default.
• W2022606182 citedByCount "25" @default.
• W2022606182 countsByYear W20226061822012 @default.
• W2022606182 countsByYear W20226061822013 @default.
• W2022606182 countsByYear W20226061822014 @default.
• W2022606182 countsByYear W20226061822016 @default.
• W2022606182 countsByYear W20226061822017 @default.
• W2022606182 countsByYear W20226061822019 @default.
• W2022606182 countsByYear W20226061822022 @default.
• W2022606182 countsByYear W20226061822023 @default.
• W2022606182 crossrefType "journal-article" @default.
• W2022606182 hasAuthorship W2022606182A5008350987 @default.
• W2022606182 hasAuthorship W2022606182A5009798637 @default.
• W2022606182 hasAuthorship W2022606182A5053105738 @default.
• W2022606182 hasAuthorship W2022606182A5053619846 @default.
• W2022606182 hasAuthorship W2022606182A5065439532 @default.
• W2022606182 hasAuthorship W2022606182A5083192393 @default.
• W2022606182 hasBestOaLocation W20226061821 @default.
• W2022606182 hasConcept C121608353 @default.
• W2022606182 hasConcept C126322002 @default.
• W2022606182 hasConcept C142724271 @default.
• W2022606182 hasConcept C150903083 @default.
• W2022606182 hasConcept C190283241 @default.
• W2022606182 hasConcept C207001950 @default.
• W2022606182 hasConcept C2776056115 @default.
• W2022606182 hasConcept C2776436680 @default.
• W2022606182 hasConcept C2776737053 @default.
• W2022606182 hasConcept C2777996000 @default.
• W2022606182 hasConcept C2778271429 @default.
• W2022606182 hasConcept C2778764654 @default.
• W2022606182 hasConcept C2780210213 @default.
• W2022606182 hasConcept C2780394083 @default.
• W2022606182 hasConcept C502942594 @default.
• W2022606182 hasConcept C55493867 @default.
• W2022606182 hasConcept C71924100 @default.
• W2022606182 hasConcept C86803240 @default.
• W2022606182 hasConcept C96232424 @default.
• W2022606182 hasConcept C99194444 @default.
• W2022606182 hasConceptScore W2022606182C121608353 @default.
• W2022606182 hasConceptScore W2022606182C126322002 @default.
• W2022606182 hasConceptScore W2022606182C142724271 @default.
• W2022606182 hasConceptScore W2022606182C150903083 @default.
• W2022606182 hasConceptScore W2022606182C190283241 @default.
• W2022606182 hasConceptScore W2022606182C207001950 @default.
• W2022606182 hasConceptScore W2022606182C2776056115 @default.
• W2022606182 hasConceptScore W2022606182C2776436680 @default.

• next